SNBR stock news
This page provides real-time market news, earnings updates, and company announcements related to Sleep Number Corporation (SNBR).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-17 15:23 EST
Introducing the United Relax Row: Economy Seats that Transform into a Couch for More Comfortable International Travel
Finviz2026-03-24 18:03:37
Incannex Healthcare Announces Partnership with the AASM Foundation in Support of Sleep Apnea Research
Finviz2026-03-25 12:03:57
Neurocrine Biosciences Presents First Expert Consensus Recommendations for Tardive Dyskinesia in Long-Term Care Settings
Finviz2026-03-26 12:31:08
Vivos Therapeutics Reports that Supported Professional Practices Have Achieved 'In-Network' Status Across Multiple Commercial Health Insurers and Medicare in Key Nevada Market
Finviz2026-03-26 12:48:47
Arcutis Presents New Phase 2 Results in Infants with Atopic Dermatitis in Late-Breaking Session Today at the 2026 American Academy of Dermatology Annual Meeting
Finviz2026-03-28 15:03:53
Hope Therapeutics, an NRx Pharmaceuticals Subsidiary (Nasdaq:NRXP), Announces Strategic Partnership with Emobot to Integrate its AI-Powered "Depression Thermometer" Across its Interventional Psychiatry Network
Finviz2026-03-30 11:03:48
BullFrog AI Announces Commercial Agreement with Top 5 Global Pharmaceutical Company to Identify and Prioritize Therapeutic Target in Major Depressive Disorder
Finviz2026-03-30 11:33:47
Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
Finviz2026-03-31 10:48:09
Natural Cycles integration unlocks FDA-cleared birth control app for users with select Garmin smartwatches
Finviz2026-03-31 11:06:46
Eli Lilly plans to acquire biotechnology company Centessa for up to $7.8 billions.
格隆汇2026-03-31 13:16:33
Axsome Therapeutics Acquires Selective PDE10A Inhibitor Balipodect for the Treatment of Schizophrenia and Other Neuropsychiatric Conditions
Finviz2026-04-01 11:03:11
Resmed to Report Third Quarter Fiscal 2026 Earnings on April 30, 2026
Finviz2026-04-01 20:06:56
Prenetics Announces NBA Champion and Two-Time MVP Giannis Antetokounmpo as IM8 Global Partner and Shareholder in Multi-Year Partnership
Finviz2026-04-02 13:03:05
Arkansas Otolaryngology Center Selects CareCloud to Power Next-Level Practice Management and Revenue Optimization with AI-Enabled Solutions
Finviz2026-04-06 11:03:55
Inspire Medical Systems, Inc. to Report First Quarter 2026 Financial Results on May 4, 2026
Finviz2026-04-06 12:03:14
Revelation Biosciences Announces Formation of Acute Kidney Injury Advisory Board
Finviz2026-04-06 13:00:53
Invivyd Launches "Antibodies for Any Body" in Partnership with World Champion Skier Lindsey Vonn to Inspire Actions that Help Support Immune Health
Finviz2026-04-07 11:03:41
Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners
Finviz2026-04-07 12:48:07
Axsome Therapeutics to Report First Quarter 2026 Financial Results on May 4
Finviz2026-04-08 11:03:45
Foundayo (orforglipron), Lilly's new oral GLP-1 pill for weight loss, now available in the U.S.
Finviz2026-04-09 10:48:06
Nexalin Announces Peer-Reviewed Study Showing the Company's DIFS Technology Reduced Self-Injury and Depression Symptoms in Female Adolescents
Finviz2026-04-09 11:51:48
Cardiff Oncology Announces Key Leadership Appointments to Strengthen Executive Team for Next Phase of Growth
Finviz2026-04-09 20:06:07
Neurocrine Biosciences Presents First Real-World Head-to-Head Claims Analysis Demonstrating Greater Treatment Persistence with INGREZZA (valbenazine) Capsules Compared to AUSTEDO XR
Finviz2026-04-14 12:33:59
NYSE Content Update: OpenLoop Health Debuts At-Home Sleep Apnea Test with 98% Accuracy
Finviz2026-04-14 12:57:48
Arcutis Presents New Phase 2 Results in Infants with Atopic Dermatitis in Late-Breaking Session Today at the 2026 American Academy of Dermatology Annual Meeting
Finviz2026-03-28 15:03:53
Hope Therapeutics, an NRx Pharmaceuticals Subsidiary (Nasdaq:NRXP), Announces Strategic Partnership with Emobot to Integrate its AI-Powered "Depression Thermometer" Across its Interventional Psychiatry Network
Finviz2026-03-30 11:03:48
BullFrog AI Announces Commercial Agreement with Top 5 Global Pharmaceutical Company to Identify and Prioritize Therapeutic Target in Major Depressive Disorder
Finviz2026-03-30 11:33:47
Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
Finviz2026-03-31 10:48:09
Natural Cycles integration unlocks FDA-cleared birth control app for users with select Garmin smartwatches
Finviz2026-03-31 11:06:46
Eli Lilly plans to acquire biotechnology company Centessa for up to $7.8 billions.
格隆汇2026-03-31 13:16:33
Axsome Therapeutics Acquires Selective PDE10A Inhibitor Balipodect for the Treatment of Schizophrenia and Other Neuropsychiatric Conditions
Finviz2026-04-01 11:03:11
Resmed to Report Third Quarter Fiscal 2026 Earnings on April 30, 2026
Finviz2026-04-01 20:06:56
Prenetics Announces NBA Champion and Two-Time MVP Giannis Antetokounmpo as IM8 Global Partner and Shareholder in Multi-Year Partnership
Finviz2026-04-02 13:03:05
Arkansas Otolaryngology Center Selects CareCloud to Power Next-Level Practice Management and Revenue Optimization with AI-Enabled Solutions
Finviz2026-04-06 11:03:55
Inspire Medical Systems, Inc. to Report First Quarter 2026 Financial Results on May 4, 2026
Finviz2026-04-06 12:03:14
Revelation Biosciences Announces Formation of Acute Kidney Injury Advisory Board
Finviz2026-04-06 13:00:53
Invivyd Launches "Antibodies for Any Body" in Partnership with World Champion Skier Lindsey Vonn to Inspire Actions that Help Support Immune Health
Finviz2026-04-07 11:03:41
Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners
Finviz2026-04-07 12:48:07
Axsome Therapeutics to Report First Quarter 2026 Financial Results on May 4
Finviz2026-04-08 11:03:45
Foundayo (orforglipron), Lilly's new oral GLP-1 pill for weight loss, now available in the U.S.
Finviz2026-04-09 10:48:06
Nexalin Announces Peer-Reviewed Study Showing the Company's DIFS Technology Reduced Self-Injury and Depression Symptoms in Female Adolescents
Finviz2026-04-09 11:51:48
Cardiff Oncology Announces Key Leadership Appointments to Strengthen Executive Team for Next Phase of Growth
Finviz2026-04-09 20:06:07
Neurocrine Biosciences Presents First Real-World Head-to-Head Claims Analysis Demonstrating Greater Treatment Persistence with INGREZZA (valbenazine) Capsules Compared to AUSTEDO XR
Finviz2026-04-14 12:33:59
NYSE Content Update: OpenLoop Health Debuts At-Home Sleep Apnea Test with 98% Accuracy
Finviz2026-04-14 12:57:48
SNBR stock chart
SNBR stock detailsSNBR stock price change
On the last trading day, SNBR stock closed at 2.13 USD, with a price change of -5.75% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more